IEX •
Healthcare •
Biotechnology •
Quote as of 09/11/2026 15:59
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeIEX
Market Capitalization116.65 mln
Float14.65 mln
Earnings Date11/12/2026
Piotroski F-Score
1
/ 9
Very weak
1-Year Forecast
11.11
Transformational upside
Relative Strength
2
/ 100
Severely lagging
Debt / Equity
0.01
Debt-free
ROE
-66.22
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Aardvark Therapeutics is a San Diego-based drug development company founded in 2017. It works on creating new oral medicines that trigger the body's natural balancing mechanisms to treat conditions like obesity and diabetes.
